Clinical Proteomics: From Diagnosis to Therapy

Remarkable in its scope and intensity, this booklet brings jointly proteomic methods in analysis and remedy from all medical fields, together with medical toxicology. the result's a brand new self-discipline in molecular medication that may revolutionize the therapy and prevention of melanoma, stroke and different critical diseases.
Following an outline of medical proteomics, the authors examine the applied sciences on hand, ahead of relocating directly to melanoma, cardiopulmonary ailment, diabetes and stroke. a complete part is dedicated to toxicity and the paintings is rounded off with a dialogue of the way forward for medical proteomics.Content:
Chapter 1 Preanalytical concerns in scientific Proteomic stories (pages 1–12): Roisean E. Ferguson and Rosamonde E. Banks
Chapter 2 Protein Separation by means of Two?Dimensional Electrophoresis (pages 13–29): Pamela M. Donoghue, Miroslava Stastna and Prof. Dr. Michael J. Dunn
Chapter three Protein Separation: Liquid Chromatography (pages 31–51): Miroslava Stastna and Dr. Jennifer Van Eyk
Chapter four HPLC in Protein Discovery (pages 53–60): Timothy J. Barder
Chapter five IEF research of Peptides for Biomarkers Discovery (pages 61–71): Ali R. Vaezzadeh, Catherine G. Zimmermann?Ivol, Jacques Deshusses, Alexander Scherl and Denis F. Hochstrasser
Chapter 6 Capillary Electrophoretic Separations for medical Proteomics (pages 73–88): Brian M. Balgley, Weijie Wang, Xueping Fang, Don L. DeVoe and Cheng S. Lee
Chapter 7 Quantitative Proteomics utilizing Nano?LC with excessive Accuracy Mass Spectrometry (pages 89–100): Ljiljana Pasa?Tolic, Jon M. Jacobs, Wei?Jun Qian and Richard D. Smith
Chapter eight Antibody Microarrays for Protein and Glycan Detection (pages 101–111): Songming Chen and Brian B. Haab
Chapter nine Biomarker identity: The function of Experimental layout, records, and knowledge Sharing (pages 113–120): Marc R. Wilkins
Chapter 10 functions of reliable Isotope Tagging dependent Quantitative Proteomics in melanoma study (pages 121–143): Ru Chen, Teresa A. Brentnall and Ruedi Aebersold
Chapter eleven Two?Dimensional Liquid Separations, Protein Microarrays, and Mass Spectrometry in finished research of Posttranslational differences and Biomarker Discovery in Cancers (pages 145–164): Tasneem H. Patwa, Jia Zhao, David E. Misek and David M. Lubman
Chapter 12 improvement and Use of Reversed?Phase Protein Microarrays for scientific purposes (pages 165–175): Virginia Espina, Julia Wulfkuhle, Valerie S. Calvert, Kirsten H. Edmiston, Lance A. Liotta and Emanuel F. Petricoin
Chapter thirteen Cyclin?Dependent Kinase Inhibitors and melanoma: Usefulness of Proteomic techniques in evaluate of the Molecular Mechanisms and Efficacy of Novel Therapeutics (pages 177–202): Marian Hajduch, Helena Skalnikova, Petr Halada, David Vydra, Petr Dzubak, Marta Dziechciarkova, Miroslav Strnad, Danuta Radioch, Suresh Jivan Gadher and Hana Kovarova
Chapter 14 Diagnostic Markers for tracking center Transplant Rejection (pages 203–215): Dr. Ciara A. McManus, Professor Marlene L. Rose and Prof. Dr. Michael J. Dunn
Chapter 15 The research of Microheterogeneity in Human Plasma Proteins: program to Acute Myocardial Infarction (pages 217–229): Randall W. Nelson, city A. Kiernan, Dobrin Nedelkov, Kemmons A. Tubbs and Eric E. Niederkofler
Chapter sixteen Discovery of Biomarkers for Cardiovascular illnesses (pages 231–240): Anthony O. Gramolini and Andrew Emili
Chapter 17 improvement of Biomarker improvement Pipeline: look for Myocardial Ischemia Biomarkers (pages 241–261): Qin Fu, Shijun Sheng and Dr. Jennifer E. Van Eyk
Chapter 18 The Albuminome as a device for Biomarker Discovery (pages 263–278): Rebekah L. Gundry and Robert J. Cotter
Chapter 19 program of Metabolomics to Cardiovascular Biomarker and Pathway Discovery (pages 279–293): Gregory D. Lewis and Robert E. Gerszten
Chapter 20 Urinary Biomarkers in Diabetic Nephropathy and different Glomerular ailments (pages 295–322): John M. Arthur and T. Brian Powell
Chapter 21 Pulmonary Proteomics (pages 323–347): Jan Hirsch, Lorraine B. Ware and Michael A. Matthay
Chapter 22 Proteomics supplying Insights into significant Psychiatric issues (pages 349–377): Melanie Focking, Kyla Pennington, Jane English, Prof. Dr. Michael Dunn and David Cotter
Chapter 23 Redox Proteomics research of Oxidative converted mind Proteins in Alzheimer's disorder and gentle Cognitive Impairment: Insights into the development of This Dementing disease (pages 379–401): Rukhsana Sultana and D. Allan Butterfield
Chapter 24 Toxicoproteomics: Correlating Tissue and Serum Proteomics in Liver damage (pages 403–433): B. Alex Merrick
Chapter 25 Biomarkers for Renal sickness and Uremic pollution (pages 435–452): Eric Schiffer, Harald Mischak and Raymond C. Vanholder
Chapter 26 HIV and different Viral monitors (pages 453–480): David R. Graham
Chapter 27 program of Fungal Cyclic Peptides and Metabolites (pages 481–509): Jan Nedved, Miroslav Sulc, Alexandr Jegorov, Anastassios Giannakopulos and Vladimir Havlicek
Chapter 28 Microarray methods to Autoantibody Profiling (pages 511–532): John M. Astle and Thomas Kodadek
Chapter 29 identity of Tumor Antigen Directed Autoantibodies (pages 533–547): Sandra Faca and Sam Hanash
Chapter 30 Antibody and opposite seize Protein Microarrays for medical Proteomics (pages 549–569): Harvey B. Pollard, Ofer Eidelman, Meera Srivastava, Catherine Joswik, Stephen Rothwell, Gregory P. Mueller, David M. Jacobowitz, William B. Guggino, Jerry Wright, Pamela L. Zeitlin and Cloud P. Paweletz
Chapter 31 Use of Antibody Microarrays within the research of irritation, Autoimmunity, Viral an infection, and melanoma Metastases (pages 571–592): Rodney Lui, Angus Brown, Bosco Wu, Ming?Wei Lin, John Thompson, Filip Braet, Wayne Dyer, JoDee Lattimore, Peter Macdonald, Stephen Adelstein and Cristobal G. dos Remedios
Chapter 32 the longer term: Translation from Discovery to the health facility – Roles of HUPO and in Biomarker Discovery (pages 593–613): Gilbert S. Omenn and Peipei Ping
Chapter 33 necessities of an outstanding Biomarker: Translation into the scientific Laboratory (pages 615–631): Mario Plebani, Martina Zaninotto and Monica Maria Mion
Chapter 34 Translation of Protein Biomarkers for scientific improvement (pages 633–651): Ian McCaffery, V. Dan Fitzpatrick, Shen Wu Wang, John M. Rossi, Haifeng Bao, Sid V. Suggs, John Ferbas and Scott D. Patterson

Show description

Read Online or Download Clinical Proteomics: From Diagnosis to Therapy PDF

Best diagnosis books

DeGowin's Diagnostic Examination

The vintage inner drugs handbook for college kids and citizens! this useful advisor addresses actual exam innovations and approaches whereas offering a catalog of scientific findings as a result of the actual exam. completely reorganized, the 8th version of DeGowin's Diagnostic exam contains a extra straightforward, easy-access layout than prior variants.

Heart Disease Diagnosis and Therapy: A Practical Approach

Throughout North the USA and around the globe, normal internists render care to greater than 60% of sufferers with cardiac difficulties. during this re-creation of the warmly got center disorder analysis and remedy: a realistic process, moment version, M. Gabriel Khan, MD, concisely assembles in a reader-friendly layout the entire clinically beneficial details that internists desire in either day-by-day rounds and busy place of work practices to discover right scientific diagnoses and select optimum pharmacologic treatments for his or her sufferers.

Additional resources for Clinical Proteomics: From Diagnosis to Therapy

Sample text

A. W. and Dunger, D. B. (2000) Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. Diabetic Medicine, 17, 7–14. Townsend, J. , Sadler, W. A. and Shanks, G. M. (1987) The effect of storage pH on the precipitation of proteins in deep frozen urine specimens. Annals of Clinical Biochemistry, 24, 111–112. 13 2 Protein Separation by Two-Dimensional Electrophoresis Pamela M. Donoghue, Miroslava Stastna, Michael J. 1 Introduction Two-dimensional gel electrophoresis (2DE) and its associated technologies have come in for considerable criticism in recent times mainly because of their supposed lack of specificity, reproducibility, and unsuitability for the analysis of certain protein subsets.

Currie, R. M. and Young, D. S. (1982) Two-dimensional gel electrophoresis of serum specimens from a normal population. Clinical Chemistry, 28, 890–899. Nelsestuen, G. , Martinez, M. , Key, N. , Sinaiko, A. and Kasthuri, R. S. 9 10 1 Preanalytical Issues in Clinical Proteomic Studies 11 12 13 14 15 16 17 (2005) Plasma protein profiling: unique and stable features of individuals. Proteomics, 5, 4012–4024. Mitchell, B. , Lampe, J. , Gafken, P. R. and Lampe, P. D. (2005) Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of a2-HS glycoprotein B-chain as a biomarker of diet.

And Omenn, G. S. (2005) Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics, 5, 3278– 3291. , Maler, J. , Kornhuber, J. and Wiltfang, J. (2006) Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid b peptides. Clinical Chemistry, 52, 332–334. Drake, S. , Bowen, R. A. , Remaley, A. T. and Hortin, G. L. (2004) Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides.

Download PDF sample

Rated 4.80 of 5 – based on 27 votes